NFKB1 and systemic lupus erythematosus: The MAPK signal pathway is known to contribute to the inhibition of nuclear factor-κB (NF-κB), which may be a potential intracellular mechanism leading to excessive lymphocyte activity in SLE (Wong et al., 2009).